🔴 Immunic is trading 5% down today with no clear catalyst identified

Immunic is trading 5.03% down now at $12.45, with no clear company-specific catalyst identified as of September 8, 2026.

• No company-specific announcement, downgrade, clinical update, or other catalyst dated September 8, 2026 was identified.
• The next scheduled event is a relapsing multiple sclerosis R&D Day on September 9, 2026, rather than a new announcement today.
• Volume is approximately 421,230 shares versus a 297,630-share average, indicating elevated activity without a confirmed reason.